Biohit Oyj — AGM Information 2020

Sep 16, 2020

Disclosure 387145

Biohit Oyj - Other information disclosed according to the rules of the Exchange

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj Other information disclosed according to the rules of the Exchange September 16, 2020 at 6.00 pm local time (EET) Biohit Oyj’s Board of Directors has in its meeting today elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com